TE_73
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L2a_3end |
|---|---|
| TE superfamily | L2 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 0.70 |
| Counts of samples | TCGA_tumor:84; TCGA_normal:22; GTEx:113 |
| TSS | chr1(-):8143634 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_73.1 | - | Intergenic | Non-coding | Non-coding | chr1(-):8136413,8136433,8137851,8138142,8143514,8143635 |
| teRNA_73.2 | - | Intergenic | Non-coding | Non-coding | chr1(-):8129218,8129238,8137851,8138142,8143514,8143635 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
